Special issue trailer: Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed?
Main Author: | Iris Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-12-01
|
Series: | Brain Hemorrhages |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589238X23000487 |
Similar Items
-
Clazosentan, first approval in Japan: Has perioperative management of subarachnoid hemorrhage changed?
by: Hidenori Suzuki
Published: (2024-04-01) -
Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan
by: Takuma Maeda, et al.
Published: (2024-01-01) -
Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?
by: Eiji Shikata, et al.
Published: (2024-04-01) -
Call for papers: Special issue on brain aneurysms and subarachnoid hemorrhage
by: Iris Tang
Published: (2023-12-01) -
Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage
by: Hidenori Suzuki, et al.
Published: (2024-04-01)